Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA), ISIN INE044A01036 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SUNPHARMA last traded at ₹1906.15 (+2.48%), with a 52-week range of ₹1583.70 to ₹2046.90 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 52.68%, FIIs 14.36%, DIIs 22.27%, mutual funds 13.01%.
EquiSense Score (ECS): 75/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.